Q4 2024 Management View CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and ...

The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

German retail sales rose in 2024, but growth should be more modest this year due to the high level of uncertainty, according ...

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The ...

Shares in LVMH fell in early Frankfurt trading on Wednesday, as sales growth posted by the luxury goods group failed to ...

CEO Mikael Bratt highlighted a record-breaking quarter with all-time highs in operating profit, operating margin, and earnings per share, despite a 5% year-over-year decrease in sales due to currency ...

"With investors highly tuned into how AI spend will represent real revenue for big tech, Apple's results have ...

Read about RTX's fourth-quarter financial performance, including 9 percent sales growth and $218 billion in total backlog.

General Dynamics faces challenges in the aerospace and submarine segments, impacting performance, but growth expected, ...

Apple reported $18.5 billion in sales in greater China last quarter, comfortably below consensus estimates of $20.9 billion.

Truist Securities analyst Jake Bartlett reiterated a Buy rating on the shares of Sysco Corp (NYSE:SYY) and lowered the price ...

The company has heavily advertised AI features since the latest iPhones were released in September.